SynthesisFrontiers in parasitology2026
Synthesis in Frontiers in parasitology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Giardiasis, caused by Methods: The review was conducted in accordance with the PRISMA 2020 guidelines, using searches in the PubMed, LILACS, and SciELO databases for studies published between 2016 and March 2026. Results: A total of 114 studies involving humans, animals, and environmental samples were included. Only nine of these studies (7.9%) adopted a genuinely integrated One Health design that simultaneously evaluated two or more compartments, and assemblage-level molecular characterization was available for only 17 studies (14.9%); these proportions should be considered when interpreting the One Health framing and the molecular inferences of this review. Substantial methodological heterogeneity was observed across studies, encompassing different coproparasitological, immunological, and molecular methods. In humans, occurrence was higher in vulnerable populations and in areas with inadequate basic sanitation. Among animals, dogs, cats, cattle, and wildlife stood out as important hosts. In environmental samples, a high frequency of detection was recorded in water, sewage, and food. Molecularly, assemblages A and B predominated, both associated with zoonotic and anthroponotic transmission. Discussion: The findings reinforce the importance of integrated surveillance and One Health approaches for the control of giardiasis in Brazil.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.